首页|MLR、NHR在心血管疾病中的研究进展

MLR、NHR在心血管疾病中的研究进展

扫码查看
心血管疾病已在全世界范围内成为危害人类生命健康的主要原因之一,具有发病率、致残率、死亡率、复发率高及并发症多等特点.近年来研究发现,炎症因子在心血管疾病的发展中起着重要作用.单核细胞与淋巴细胞比值(MLR)、中性粒细胞与高密度脂蛋白比值(NHR)是近几年新发现的新型炎症指标,它们与心血管疾病关系密切.本文阐述了MLR、NHR与冠心病和心力衰竭的关系,MLR与急性心肌炎、心房颤动的关系及NHR与老年退行性心脏瓣膜病的关系,为心血管疾病的预防和治疗提供新的思路和方法.本文就MLR、NHR在心血管疾病中的研究进展进行综述.
Research Progress of MLR and NHR in Cardiovascular Diseases
Cardiovascular disease has become one of the main reasons endangering human life and health worldwide,with the characteristics of high incidence rate,high disability rate,high mortality,high recurrence rate and many complications.In recent years,studies have found that inflammatory factors play an important role in the development of cardiovascular diseases.The monocyte to lymphocyte ratio (MLR) and neutrophil to high-density lipoprotein ratio (NHR) are newly discovered inflammatory markers in recent years,which are closely related to cardiovascular disease.This article elaborates on the relationship between MLR,NHR and coronary heart disease and heart failure,the relationship between MLR and acute myocarditis,atrial fibrillation,and the relationship between NHR and degenerative heart valve disease in the elderly,providing new ideas and methods for the prevention and treatment of cardiovascular diseases.This article reviews the research progress of MLR and NHR in cardiovascular diseases.

Monocyte to lymphocyte ratioNeutrophil to high-density lipoprotein ratioCardiovascular disease

罗升、魏晓娟

展开 >

青海大学研究生院 青海 西宁 810000

青海省人民医院心血管内科 青海 西宁 810000

单核细胞与淋巴细胞比值 中性粒细胞与高密度脂蛋白比值 心血管疾病

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(36)